Amneal Pharmaceuticals (AMRX) Misses Q1 EPS by 4c, Revenues Beat; Affirms FY19 EPS Outlook
Go back to Amneal Pharmaceuticals (AMRX) Misses Q1 EPS by 4c, Revenues Beat; Affirms FY19 EPS Outlook| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 16.11 -0.1 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $16.21 | 52 Week High | $0.19 | |||
| Open | $16.21 | 52 Week Low | $0.07 | |||
| Day High | $16.40 | P/E | N/A | |||
| Day Low | $16.02 | EPS | $-0.01 | |||
| Volume | 1,794,259 | |||||
